Immune Checkpoint Inhibitor-Related Hypophysitis: A Call for Vigilance
Author:
Open Access
- 30 June 2025
- journal article
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 40 (3) , 391-393
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Clinical outcomes of endocrine and other disorders induced by immune checkpoint inhibitors in Japanese patientsScientific Reports, 2025
- Immune-related adverse events of immune checkpoint inhibitors: a reviewFrontiers in Immunology, 2023
- Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine SocietyEndocrinology and Metabolism, 2022
- Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guidelineEuropean Journal of Endocrinology, 2022
- Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammationBest Practice & Research Clinical Endocrinology & Metabolism, 2019
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillanceNature Reviews Clinical Oncology, 2019
- Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine SocietyEndocrine Journal, 2019
- Cancer immunotherapy using checkpoint blockadeScience, 2018
- Immune-Related Adverse Events Associated with Immune Checkpoint BlockadeNew England Journal of Medicine, 2018
- Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insightsPituitary, 2015